prognosis

Open Access
CYBA as a Potential Biomarker for Renal Cell Carcinoma: Evidence from an Integrated Genetic Analysis
CHI-FEN CHANG, SHU-PIN HUANG, YU-MEI HSUEH, PEI-LING CHEN, CHENG-HSUEH LEE, JIUN-HUNG GENG, CHAO-YUAN HUANG and BO-YING BAO

Cancer Genomics & Proteomics September 2023, 20 (5) 469-475; DOI: https://doi.org/10.21873/cgp.20398
Open Access
Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma
VLASTIMIL KULDA, JIRI POLIVKA, MARTIN SVATON, TOMAS VANECEK, MARCELA BURESOVA, KATERINA HOUFKOVA, MAHYAR SHARIF BAGHERI, TEREZA KNIZKOVA, BOHUSLAVA VANKOVA, JINDRA WINDRICHOVA, PETR MACAN, VACLAV BABUSKA and MARTIN PESTA

Cancer Genomics & Proteomics July 2023, 20 (4) 404-411; DOI: https://doi.org/10.21873/cgp.20392
Open Access
Loss of F-Box and Leucine Rich Repeat Protein 5 (FBXL5) Expression Is Associated With Poor Survival in Patients With Hepatocellular Carcinoma After Curative Resection: A Two-institute Study
YOON AH CHO, SUNG-EUN KIM, CHEOL KEUN PARK, HYUN HEE KOH, CHEOL-KEUN PARK and SANG YUN HA

Cancer Genomics & Proteomics May 2023, 20 (3) 298-307; DOI: https://doi.org/10.21873/cgp.20382
Open Access
Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis
AKINORI MINATO, YUZAN KUDO, HIROTSUGU NOGUCHI, SHIRO KOHI, YOSHITAKA HASEGAWA, NORIHIRO SATO, KEIJI HIRATA and NAOHIRO FUJIMOTO

Cancer Genomics & Proteomics March 2023, 20 (2) 203-210; DOI: https://doi.org/10.21873/cgp.20375
Open Access
TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis
GWAN HEE HAN, HEE YUN, JOON-YONG CHUNG, JAE-HOON KIM and HANBYOUL CHO

Cancer Genomics & Proteomics November 2022, 19 (6) 692-702; DOI: https://doi.org/10.21873/cgp.20352
Open Access
Identification of a Novel Long Non-coding RNA, lnc-ATMIN-4:2, and its Clinicopathological and Prognostic Significance in Advanced Gastric Cancer
EOJIN KIM, HYUNJIN KIM, MIN-KYUNG YEO, CHUL HWAN KIM, JOO YOUNG KIM, SUNGSOO PARK, HYUN-SOO KIM and YANG-SEOK CHAE

Cancer Genomics & Proteomics November 2022, 19 (6) 761-772; DOI: https://doi.org/10.21873/cgp.20358
Open Access
Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA

Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
Open Access
Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA

Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
Open Access
Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA

Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
Open Access
Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA

Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340

Main menu

User menu

Search

prognosis

Pages